We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 14th:
Aldeyra Therapeutics, Inc. (ALDX - Free Report) : This biotechnology company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 29.1% over the last 60 days.
ChannelAdvisor Corporation : This provider of software-as-a-service solutions has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 32.7% over the last 60 days.
HTG Molecular Diagnostics, Inc. : This commercial stage life sciences company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.7% over the last 60 days.
Glu Mobile Inc. : This developer of free-to-play mobile games has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 11.5% over the last 60 days.
From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.
This young company’s gigantic growth was hidden by low-volume trading, then cut short by the coronavirus. But its digital products stand out in a region where the internet economy has tripled since 2015 and looks to triple again by 2025.
Its stock price is already starting to resume its upward arc. The sky’s the limit! And the earlier you get in, the greater your potential gain.
Image: Bigstock
Top Ranked Momentum Stocks to Buy for May 14th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, May 14th:
Aldeyra Therapeutics, Inc. (ALDX - Free Report) : This biotechnology company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 29.1% over the last 60 days.
Aldeyra Therapeutics Inc Price and Consensus
Aldeyra Therapeutics Inc price-consensus-chart | Aldeyra Therapeutics Inc Quote
Aldeyra Therapeutics’ shares gained 35.1% over the last one month above the S&P 500’s rise of 2.1%. The company possesses a Momentum Score of A.
Aldeyra Therapeutics Inc Price
Aldeyra Therapeutics Inc price | Aldeyra Therapeutics Inc Quote
ChannelAdvisor Corporation : This provider of software-as-a-service solutions has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 32.7% over the last 60 days.
ChannelAdvisor Corporation Price and Consensus
ChannelAdvisor Corporation price-consensus-chart | ChannelAdvisor Corporation Quote
ChannelAdvisor’s shares gained 60.5% over the last one month. The company possesses a Momentum Score of B.
ChannelAdvisor Corporation Price
ChannelAdvisor Corporation price | ChannelAdvisor Corporation Quote
HTG Molecular Diagnostics, Inc. : This commercial stage life sciences company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.7% over the last 60 days.
HTG Molecular Diagnostics Inc Price and Consensus
HTG Molecular Diagnostics Inc price-consensus-chart | HTG Molecular Diagnostics Inc Quote
HTG Molecular Diagnostics’ shares gained 23.4% over the last one month. The company possesses a Momentum Score of A.
HTG Molecular Diagnostics Inc Price
HTG Molecular Diagnostics Inc price | HTG Molecular Diagnostics Inc Quote
Glu Mobile Inc. : This developer of free-to-play mobile games has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 11.5% over the last 60 days.
Glu Mobile Inc Price and Consensus
Glu Mobile Inc price-consensus-chart | Glu Mobile Inc Quote
Glu Mobile’s shares gained 54.7% over the last one month. The company possesses a Momentum Score of B.
Glu Mobile Inc Price
Glu Mobile Inc price | Glu Mobile Inc Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Zacks’ Single Best Pick to Double
From thousands of stocks, 5 Zacks experts each picked their favorite to gain +100% or more in months to come. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.
This young company’s gigantic growth was hidden by low-volume trading, then cut short by the coronavirus. But its digital products stand out in a region where the internet economy has tripled since 2015 and looks to triple again by 2025.
Its stock price is already starting to resume its upward arc. The sky’s the limit! And the earlier you get in, the greater your potential gain.
Click Here, See It Free >>